Key Segments:
By Product
-
Kits & Reagents
-
Enzymes
-
Instruments & Software
-
Services
By Technology
-
Sequencing
-
Polymerase Chain Reaction
-
Microarray
-
Others
By Application
-
Clinical Research
-
Diagnostics
-
Gene Therapy
-
Others
By End User
-
Pharmaceutical & Biotechnology Companies
-
Hospital & Diagnostic Laboratories
-
Research & Academia
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes Illumina, Zymo Research, QIAGEN, New England Biolabs, Agilent, Thermo Fisher Scientific, Merck KGaA, Diagenode, Epigentek, Active Motif, Takara Bio, biomodal, Oxford Nanopore, Pacific Biosciences, Novogene, Guardant Health, and Bio-Rad, among others.
The main opportunities lie in coverage for multi-cancer early detection, and enzymatic and positive-readout conversion methods. Artificial intelligence classifiers and long-read multi-base technologies add further potential.
The key growth factor is the use of methylation signatures for earlier cancer detection, together with falling sequencing costs that make large studies and clinical panels affordable.
By product, the Kits and Reagents segment dominated the market with approximately 42.50% share in 2025, supported by the recurring consumption of conversion and library preparation chemistry.
North America dominated the market with approximately 38.76% share in 2025, supported by research funding and early adoption of clinical tests. Asia Pacific is the fastest-growing region with a projected CAGR of 15.15% from 2026 to 2035.
